Guy De Backer
About
In The Last Decade
Guy De Backer
298 papers receiving 23.2k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Cardiology and Cardiovascular Medicine 12.3k
- Surgery 7.5k
- Endocrinology, Diabetes and Metabolism 5.6k
- Public Health, Environmental and Occupational Health 2.7k
- Economics and Econometrics 2.7k
Countries citing papers authored by Guy De Backer
This map shows the geographic impact of Guy De Backer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy De Backer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy De Backer more than expected).
Fields of papers citing papers by Guy De Backer
This network shows the impact of papers produced by Guy De Backer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy De Backer. The network helps show where Guy De Backer may publish in the future.
Co-authorship network of co-authors of Guy De Backer
This figure shows the co-authorship network connecting the top 25 collaborators of Guy De Backer. A scholar is included among the top collaborators of Guy De Backer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy De Backer. Guy De Backer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias breakdown → | 16 |
| 2 | 48 | |
| 3 | 9 | |
| 4 | 5 | |
| 5 | 4 | |
| 6 | [New European guidelines for the management of dyslipidaemia in cardiovascular prevention]. | 1 |
| 7 | Les nouvelles recommandations Europeennes pour le traitement des dyslipidemies en prevention cardiovasculaire. | 1 |
| 8 | 70 | |
| 9 | Abstract 3537: Oral Contraceptives Cause Major C-reactive Protein Rises in the Female General Population | 0 |
| 10 | Abstract 1902: Prevalence Of Atherosclerosis in Middle-age: Results from the Asklepios Study in 2524 Subjects Free from Overt Cardiovascular Disease | 1 |
| 11 | High prevalence of diabetes mellitus and metabolic syndrome in the BEST study ("Belgian Evaluation of Screening and Treatment of high risk patients based on waist and age") | 2 |
| 12 | 1 | |
| 13 | Job Stress, Absenteeism and Coronary Heart Disease in Europe (JACE) a Multicenter Prospective Study | 1 |
| 14 | 24 | |
| 15 | Prevention of coronary heart disease in clinical practice | 48 |
| 16 | Prevalence and significance of ventricular premature beats in 1968 employed men | 1 |
| 17 | Facteurs psychologiques et cardiopathies ischémiques | 3 |
| 18 | Intermittent claudication--epidemiology and natural history. | 38 |
| 19 | The Belgian multifactor preventive trial in CVD (III): Smoking habits and socio-biological variables | 3 |
| 20 | Modification of cardiovascular risk in a controlled multifactorial prevention trial | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.